Mouse-adapted SARS-CoV-2 model provides new tool for COVID-19 discoveries

August 31, 2020

A new COVID-19 mouse model developed at the University of North Carolina at Chapel Hill captures many of the features of human disease and has helped advance a vaccine candidate to clinical trial.